当前位置: 首页 >> 检索结果
共有 4314 条符合本次的查询结果, 用时 3.9775079 秒

3841. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome-Associated Colorectal Carcinomas.

作者: Noah C Helderman.;Anne-Sophie Van Der Werf-'t Lam.; .;Hans Morreau.;Arnoud Boot.;Tom Van Wezel.;Maartje Nielsen.
来源: Gastroenterology. 2023年165卷1期271-274.e2页

3842. A novel capsule endoscopy for upper and mid-GI tract: the UMGI capsule.

作者: Bin Jiang.;Yang-Yang Qian.;Yuan-Chen Wang.;Jun Pan.;Xi Jiang.;Jia-Hui Zhu.;Xiao-Ou Qiu.;Wei Zhou.;Zhao-Shen Li.;Zhuan Liao.
来源: BMC Gastroenterol. 2023年23卷1期76页
Complete and consecutive observation of the gastrointestinal (GI) tract continues to present challenges for current endoscopy systems. We developed a novel upper and mid gastrointestinal (UMGI) capsule endoscopy using the modified detachable string magnetically controlled capsule endoscopy (DS-MCE) and inspection method and aimed to assess the clinical application.

3843. PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis.

作者: Michael Trauner.;Chuhan Chung.;Kate Sterling.;Xiangyu Liu.;Xiaomin Lu.;Jun Xu.;Clare Tempany-Afdhal.;Zachary D Goodman.;Martti Färkkilä.;Atsushi Tanaka.;Palak Trivedi.;Kris V Kowdley.;Christopher L Bowlus.;Cynthia Levy.;Robert P Myers.
来源: BMC Gastroenterol. 2023年23卷1期75页
Primary sclerosing cholangitis (PSC) is a chronic progressive liver disease leading to biliary fibrosis and cirrhosis. Cilofexor is a nonsteroidal farnesoid X receptor agonist that demonstrated significant improvements in liver biochemistry and markers of cholestasis in patients with PSC in a phase 2 study. We describe here the rationale, design, and implementation of the phase 3 PRIMIS trial, the largest placebo-controlled trial in PSC.

3844. Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma.

作者: Jing Chen.;Kuai Liu.;Yikai Luo.;Muxing Kang.;Jun Wang.;Guofeng Chen.;Jia Qi.;Wenxuan Wu.;Beidi Wang.;Yaxuan Han.;Le Shi.;Kefan Wang.;Xiaying Han.;Xiaojing Ma.;Wei Liu.;Yuan Ding.;Liangjing Wang.;Han Liang.;Lie Wang.;Jian Chen.
来源: Gastroenterology. 2023年165卷1期88-103页
Gastric cancer (GC) is a major cancer type characterized by high heterogeneity in both tumor cells and the tumor immune microenvironment (TIME). One intractable GC subtype is gastric signet-ring cell carcinoma (GSRCC), which is associated with poor prognosis. However, it remains unclear what the GSRCC TIME characteristics are and how these characteristics may contribute to clinical outcomes.

3845. Comprehensive analysis of the biological function and immune infiltration of SLC38A2 in gastric cancer.

作者: Liang Zhu.;Zhengguang Wang.;Wenxiu Han.;Aman Xu.
来源: BMC Gastroenterol. 2023年23卷1期74页
Solute carrier family 38 member 2 (SLC38A2) has previously been reported to participate in carcinogenesis. However, its expression and function in gastric cancer (GC) remain unclear. The present study aimed to investigate the role of SLC38A2 in GC.

3846. Sources of information on surgical options for patients undergoing antireflux surgery: a single-center questionnaire-based survey.

作者: Ningying Ruan.;Hao Chen.;Zhifei Wang.;Jinlei Mao.;Jianfu Xia.;Fei Zhao.;Ting Zhang.
来源: BMC Gastroenterol. 2023年23卷1期73页
To explore the sources of information on antireflux surgery for patients undergoing this surgery in China.

3847. Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma.

作者: Rui-Qiu Chen.;Zhi-Lei Zhang.;Yu-Ming Jia.;Rui-Xiang Chen.;Li Peng.
来源: BMC Gastroenterol. 2023年23卷1期72页
In recent years, more and more inflammatory indicators have been studied to predict the long-term survival of patients with ampullary carcinoma (AC) after radical resection, but these prognostic indicators are still controversial. Therefore, based on previous inflammation scores, this study established a novel, easily accessible, more feasible and more predictive prognostic marker [Carbohydrate antigen199 to gamma-glutamyltransferase ratio (CA19-9/GGT)] to better assess the prognostic significance in AC patients undergoing radical resection.

3848. Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study.

作者: Severin A Lautenschlager.;Mamadou Pathé Barry.;Gerhard Rogler.;Luc Biedermann.;Philipp Schreiner.;Alexander R Siebenhüner.; .
来源: BMC Gastroenterol. 2023年23卷1期71页
Various environmental risk factors have been associated with the pathogenesis of inflammatory bowel disease. In this study we aimed to identify lifestyle factors that affect the onset of Crohn's disease and ulcerative colitis.

3849. BMPR2 as a Novel Predisposition Gene for Hereditary Colorectal Polyposis.

作者: Laia Bonjoch.;Ceres Fernandez-Rozadilla.;Miriam Alvarez-Barona.;Anael Lopez-Novo.;Cristina Herrera-Pariente.;Jorge Amigo.;Luis Bujanda.;David Remedios.;Andrés Dacal.;Joaquín Cubiella.;Francesc Balaguer.;Fernando Fernández-Bañares.;Angel Carracedo.;Rodrigo Jover.;Sergi Castellvi-Bel.;Clara Ruiz-Ponte.
来源: Gastroenterology. 2023年165卷1期162-172.e5页
Colorectal cancer (CRC) is one of the most prevalent tumors worldwide, with incidence quickly increasing (particularly in the context of early-onset cases), despite important prevention efforts, mainly in the form of population-wide screening programs. Although many cases present a clear familial component, the current list of hereditary CRC genes leaves a considerable proportion of the cases unexplained.

3850. A "Two-in-One Hit" Model of Shortcut Carcinogenesis in MLH1 Lynch Syndrome Carriers.

作者: Aysel Ahadova.;Albrecht Stenzinger.;Toni Seppälä.;Robert Hüneburg.;Matthias Kloor.;Hendrik Bläker.; .
来源: Gastroenterology. 2023年165卷1期267-270.e4页

3851. The Efficacy of Peroral Endoscopic Myotomy vs Pneumatic Dilation as Treatment for Patients With Achalasia Suffering From Persistent or Recurrent Symptoms After Laparoscopic Heller Myotomy: A Randomized Clinical Trial.

作者: Caroline M G Saleh.;Pietro Familiari.;Barbara A J Bastiaansen.;Paul Fockens.;Jan Tack.;Guy Boeckxstaens.;Raf Bisschops.;Aaltje Lei.;Marlies P Schijven.;Jan Guido Costamagna.;Albert J Bredenoord.
来源: Gastroenterology. 2023年164卷7期1108-1118.e3页
For patients with achalasia experiencing persistent or recurrent symptoms after laparoscopic Heller myotomy (LHM), pneumatic dilation (PD) is the most frequently used treatment. Per-oral endoscopic myotomy (POEM) is increasingly being investigated as rescue therapy. This study aimed to determine the efficacy of POEM vs PD for patients with persistent or recurrent symptoms after LHM.

3852. A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer.

作者: Hye-Been Yoo.;Jin Woo Moon.;Hwa-Ryeon Kim.;Hee Seung Lee.;Koji Miyabayashi.;Chan Hee Park.;Sabrina Ge.;Amy Zhang.;Yoo Keung Tae.;Yujin Sub.;Hyun-Woo Park.;Heon Yung Gee.;Faiyaz Notta.;David A Tuveson.;Seungmin Bang.;Mi-Young Kim.;Jae-Seok Roe.
来源: Gastroenterology. 2023年165卷1期133-148.e17页
Pancreatic ductal adenocarcinoma (PDA), with its highly metastatic propensity, is one of the most lethal subtypes of pancreatic cancer. Although recent large-scale transcriptomic studies have demonstrated that heterogeneous gene expressions play an essential role in determining molecular phenotypes of PDA, biological cues for and consequences of distinct transcriptional programs remain unclear.

3853. Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes.

作者: Akwi W Asombang.;Nathaniel Chishinga.;Mouhand F Mohamed.;Alick Nkhoma.;Jackson Chipaila.;Bright Nsokolo.;Martha Manda-Mapalo.;Joao Filipe G Montiero.;Lewis Banda.;Kulwinder S Dua.
来源: BMC Gastroenterol. 2023年23卷1期66页
The prevalence, management, and clinical outcomes of cholangiocarcinoma in Africa are unknown. The aim is to conduct a comprehensive systematic review on the epidemiology, management, and outcomes of cholangiocarcinoma in Africa.

3854. Esophageal motility disorders in symptomatic patients and its relation to age.

作者: Ahmed Abdelghani.;Alhosaeyn Ibrahim.;El-Sayed El-Sayed.;Mohammad El Sherbiny.;Ahmed Al-Badry.
来源: BMC Gastroenterol. 2023年23卷1期69页
Although swallowing disorders can impact individuals of any age, some are unique to the elderly, and others are frequent. Some disorders, such as achalasia, are diagnosed by esophageal manometry studies, which assess lower esophageal sphincter (LES) pressure and relaxation, peristalsis in the esophageal body, and contraction wave characteristics. This research aimed to evaluate esophageal motility dysfunction in symptomatic patients and its relation to age.

3855. Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma.

作者: Naoya Kanogawa.;Sadahisa Ogasawara.;Susumu Maruta.;Yotaro Iino.;Masamichi Obu.;Takamasa Ishino.;Keita Ogawa.;Sae Yumita.;Terunao Iwanaga.;Hidemi Unozawa.;Miyuki Nakagawa.;Kisako Fujiwara.;Takafumi Sakuma.;Naoto Fujita.;Ryuta Kojima.;Hiroaki Kanzaki.;Keisuke Koroki.;Kazufumi Kobayashi.;Masanori Inoue.;Soichiro Kiyono.;Masato Nakamura.;Takayuki Kondo.;Tomoko Saito.;Ryo Nakagawa.;Shingo Nakamoto.;Ryosuke Muroyama.;Tetsuhiro Chiba.;Ei Itobayashi.;Yoshihiro Koma.;Ryosaku Azemoto.;Jun Kato.;Naoya Kato.
来源: BMC Gastroenterol. 2023年23卷1期70页
Ramucirumab was shown to be effective as a second-line treatment after sorafenib in patients with advanced hepatocellular carcinoma (HCC) with alpha-fetoprotein levels > 400 ng/mL in a worldwide phase 3 trial. Ramucirumab is used in patients pretreated with various systemic therapies in clinical practice. We retrospectively examined the treatment outcomes of ramucirumab administered to advanced HCC patients after diverse systemic therapies.

3856. Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study.

作者: Xuanfeng Zhang.;Lulu Yang.;Dong Zhang.;Xiaochuan Wang.;Xuefeng Bu.;Xinhui Zhang.;Long Cui.
来源: BMC Gastroenterol. 2023年23卷1期68页
A prognostic assessment method with good sensitivity and specificity plays an important role in the treatment of pancreatic cancer patients. Finding a way to evaluate the prognosis of pancreatic cancer is of great significance for the treatment of pancreatic cancer.

3857. Change of monocytes/macrophages in ulcerative colitis patients with symptoms of anxiety and depression.

作者: Xin Gao.;Shihao Duan.;Yubin Cao.;Yan Zhang.
来源: BMC Gastroenterol. 2023年23卷1期67页
Monocytes/macrophages play important roles in inflammatory bowel disease and depression, but few studies had focused on the change of monocytes/macrophages in ulcerative colitis (UC) patients with psychiatric disorders.

3858. Abdominal Pain-An Ambiguous Pancreatic Cyst.

作者: Govind H Kallumkal.;Nathan Montgomery.;Todd H Baron.
来源: Gastroenterology. 2023年165卷4期838-839页

3859. Lymphatic Invasion of Plakoglobin-Dependent Tumor Cell Clusters Drives Formation of Polyclonal Lung Metastases in Colon Cancer.

作者: Emre Küçükköse.;Jamila Laoukili.;Alexander N Gorelick.;Sebastian Degner.;Miangela M Laclé.;Lotte van den Bent.;Niek A Peters.;André Verheem.;Wei-Ting Hung.;Nicola C Frenkel.;Emma C E Wassenaar.;Nico Lansu.;Kristiaan J Lenos.;Louis Vermeulen.;Miriam Koopman.;Jeanine M L Roodhart.;Geert J P L Kops.;Inne H M Borel Rinkes.;Jeroen Hagendoorn.;Kamila Naxerova.;Onno Kranenburg.
来源: Gastroenterology. 2023年165卷2期429-444.e15页
Patients with colon cancer with liver metastases may be cured with surgery, but the presence of additional lung metastases often precludes curative treatment. Little is known about the processes driving lung metastasis. This study aimed to elucidate the mechanisms governing lung vs liver metastasis formation.

3860. Nausea, Vomiting, and Abdominal Distention After Atrial Fibrillation Therapy.

作者: Kaitlyn Estes.;Frederick Weber.
来源: Gastroenterology. 2023年165卷1期e13-e15页
共有 4314 条符合本次的查询结果, 用时 3.9775079 秒